Staged endovascular management for non-maturing arteriovenous fistulas: A single-center retrospective cohort study
Abstract
BACKGROUND
This study aims to assess the efficacy and safety of a staged endovascular management for non-maturing arteriovenous fistulas (AVFs) and identify prognostic factors associated with patency.
METHODS
Between September 2016 and June 2025, 67 patients (age: 62.8 ± 10.8 years; male: 67.2%) underwent staged endovascular management according to a standardized institutional protocol. This strategy prioritizes correction of underlying stenotic lesions, even when the severity of stenosis is mild. Embolization of collateral veins was performed in cases of persistent maturation failure.
RESULTS
Technical and clinical success rates were 97.4% (76/78) and 83.6% (56/67), respectively, with a complication rate of 5.1% (4/78). Initial PTA achieved clinical success in 54 of 67 patients (80.6%). Among 11 patients with persistent maturation failure, four underwent collateral embolization, resulting in clinical success in 2. Postintervention primary and assisted primary patency rates at 3, 6, and 12 months were 85.7%, 81.7%, and 73.1%, and 98.2%, 96.3%, and 94.2%, respectively. Diabetes mellitus (HR, 5.43; 95% CI, 1.23-23.96; p = 0.026) and thrombotic occlusion (HR, 7.05; 95% CI, 2.62-18.93; p < 0.001) were significant predictors of reduced primary patency. The reintervention rate was 0.45 events/access-year. Outcomes did not differ significantly according to lesion characteristics.
CONCLUSIONS
A staged endovascular approach offers a safe and effective strategy for managing…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 54 participants or records.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.